NEUROTRAUMA SCIENCES
NeuroTrauma Sciences (NTS) is a biopharmaceutical company focused on developing neuroprotective and neurorestorative agents to treat brain injury including stroke, concussion, and the complications of traumatic brain injury (TBI). The company's biopharmaceuticals utilize neuroprotective and neurorestorative agents, enabling doctors to provide their patients with therapies that alleviate the cognitive, functional, and neurobehavioral effects of brain injuries.
NEUROTRAUMA SCIENCES
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Alpharetta, Georgia, United States
Country:
United States
Website Url:
http://www.neurotraumasciences.com
Total Employee:
11+
Status:
Active
Contact:
888.451.4955
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.neurotraumasciences.com Semrush global rank: 4.14 M Semrush visits lastest month: 2.9 K
Unable to get host informations!!!
More informations about "NeuroTrauma Sciences"
Home - NeuroTrauma Sciences
NeuroTrauma Sciences (NTS), founded in 2016, is a clinical stage biopharmaceutical company focused on improving the lives of stroke patients. NTS’ lead indications are acute ischemic …See details»
News & Events - NeuroTrauma Sciences
ATLANTA, GA, May 10, 2023 – NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing neuroprotective therapeutics for treating Central Nervous System (CNS) …See details»
NeuroTrauma Sciences, LLC | LinkedIn
NeuroTrauma Sciences (NTS) is a biopharmaceutical company focused on developing therapies to treat the devastating effects of stroke and traumatic brain injury (TBI), including concussion.See details»
News & Events - NeuroTrauma Sciences
May 11, 2021 · NeuroTrauma Sciences (NTS) is a biopharmaceutical company advancing its mission to develop therapies that address the full complexities of acquired brain injuries …See details»
NeuroTrauma Sciences - Crunchbase Company Profile & Funding
NeuroTrauma Sciences (NTS) is a biopharmaceutical company focused on developing neuroprotective and neurorestorative agents to treat brain injury including stroke, concussion, …See details»
Carl Long - Chief Executive Officer - NeuroTrauma …
NeuroTrauma Sciences (NTS) was founded with a charter to develop neuroprotective and neurorestorative agents to treat brain injury including stroke, concussion, and the complications of traumatic...See details»
NeuroTrauma Sciences Announces Key Appointments to its …
ATLANTA, May 10, 2023 /PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing neuroprotective therapeutics for treating Central …See details»
NeuroTrauma Sciences Announces Expansion of Its Executive …
Mar 24, 2021 · NeuroTrauma Sciences (NTS) is a biopharmaceutical company advancing its mission to develop therapies that address the full complexities of acquired brain injuries …See details»
NeuroTrauma Sciences and Henry Ford Health System Announce …
ATLANTA and DETROIT, July 16, 2018 /PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, and Henry Ford Health System, a non-profit organization, today …See details»
NeuroTrauma Sciences Announces Key Appointments …
May 10, 2023 · NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing neuroprotective therapeutics for treating Central Nervous System (CNS) injuries, including stroke and Traumatic Brain Injury announced …See details»
Science - NeuroTrauma Sciences
NTS-105 readily crosses the blood brain barrier, reaches pharmacologic concentrations in the brain and plasma, and has multi-targeted mechanisms of action. NTS-105 has a unique target receptor profile, with three equipotent …See details»
NeuroTrauma Sciences - VentureRadar
Website: https://neurotraumasciences.com/ Develops therapies for acquired brain injuries, including traumatic brain injury, stroke, and other neurological conditions, addressing …See details»
NeuroTrauma Sciences - PitchBook
Operator of a biopharmaceutical company intended to treat brain injuries including stroke, concussion, and the complications of traumatic brain injury.See details»
NeuroTrauma Sciences Enters Into Worldwide License Agreement …
Dec 11, 2019 · Under the license agreement, Emory has granted NTS an exclusive worldwide license for NTS-1104 and related compounds, proprietary and patented neuroactive …See details»
NeuroTrauma Sciences Announces Expansion of Its Executive …
Mar 24, 2021 · NeuroTrauma Sciences (NTS) is a biopharmaceutical company advancing its mission to develop therapies that address the full complexities of acquired brain injuries …See details»
News & Events - NeuroTrauma Sciences
Jun 7, 2022 · Dr. Tom Parry of NeuroTrauma Sciences Presents Update on Neuroprotective Compounds NTS-104/105 at the 12th Annual Traumatic Brain Injury ConferenceSee details»
NeuroTrauma Sciences Appoints William Fricker, CPA, MBA, as
Jan 9, 2024 · By leveraging insights into the biology of acquired brain injury, NTS is advancing a pipeline of candidates targeting ischemic stroke and TBI. For additional information, please …See details»
NeuroTrauma Sciences Commences First-in-Human Dosing in the …
ATLANTA, June 1, 2023 /PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing neuroprotective therapeutics for treating patients with …See details»
NeuroTrauma Sciences Enters Collaboration to Support "CENTER …
May 11, 2021 · NeuroTrauma Sciences (NTS) is a biopharmaceutical company advancing its mission to develop therapies that address the full complexities of acquired brain injuries …See details»
NeuroTrauma Sciences Neuroactive Compound NTS-105 …
ATLANTA, June 27, 2022 /PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic …See details»